These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10367561)

  • 1. The potentiating effect of sertraline and fluoxetine on amphetamine-induced locomotor activity is not mediated by serotonin.
    Sills TL; Greenshaw AJ; Baker GB; Fletcher PJ
    Psychopharmacology (Berl); 1999 Apr; 143(4):426-32. PubMed ID: 10367561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subchronic fluoxetine treatment induces a transient potentiation of amphetamine-induced hyperlocomotion: possible pharmacokinetic interaction.
    Sills TL; Greenshaw AJ; Baker GB; Fletcher PJ
    Behav Pharmacol; 2000 Apr; 11(2):109-16. PubMed ID: 10877115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute fluoxetine treatment potentiates amphetamine hyperactivity and amphetamine-induced nucleus accumbens dopamine release: possible pharmacokinetic interaction.
    Sills TL; Greenshaw AJ; Baker GB; Fletcher PJ
    Psychopharmacology (Berl); 1999 Feb; 141(4):421-7. PubMed ID: 10090650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: possible pharmacokinetic effects.
    Fletcher PJ; Sinyard J; Salsali M; Baker GB
    Psychopharmacology (Berl); 2004 Jul; 174(3):406-13. PubMed ID: 14740149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of standardized extracts of St. John's wort on the single-unit activity of serotonergic dorsal Raphe neurons in awake cats: comparisons with fluoxetine and sertraline.
    Fornal CA; Metzler CW; Mirescu C; Stein SK; Jacobs BL
    Neuropsychopharmacology; 2001 Dec; 25(6):858-70. PubMed ID: 11750179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synergistic effect of fluoxetine on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist.
    Maj J; Rogóz Z; Skuza G; Wedzony K
    J Neural Transm (Vienna); 1996; 103(1-2):131-46. PubMed ID: 9026367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat--interactions between the two drugs.
    Lin D; Koob GF; Markou A
    Psychopharmacology (Berl); 1999 Aug; 145(3):283-94. PubMed ID: 10494577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats.
    Rogóz Z; Skuza G
    Pharmacol Rep; 2006; 58(4):493-500. PubMed ID: 16963794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics and metabolism of perazine in the rat.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    J Pharm Pharmacol; 2001 Apr; 53(4):449-61. PubMed ID: 11341361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats.
    Harrison AA; Liem YT; Markou A
    Neuropsychopharmacology; 2001 Jul; 25(1):55-71. PubMed ID: 11377919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
    Hirano K; Kimura R; Sugimoto Y; Yamada J; Uchida S; Kato Y; Hashimoto H; Yamada S
    Br J Pharmacol; 2005 Mar; 144(5):695-702. PubMed ID: 15678084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acute administration of selective serotonin reuptake inhibitors on sympathetic nerve activity.
    Tiradentes RV; Pires JG; Silva NF; Ramage AG; Santuzzi CH; Futuro Neto HA
    Braz J Med Biol Res; 2014 Jul; 47(7):554-9. PubMed ID: 25003632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential for clinically significant drug-drug interactions involving the CYP 2D6 system: effects with fluoxetine and paroxetine versus sertraline.
    Preskorn SH; Shah R; Neff M; Golbeck AL; Choi J
    J Psychiatr Pract; 2007 Jan; 13(1):5-12. PubMed ID: 17242587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics of thioridazine and its metabolites: in vivo and in vitro studies.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):309-14. PubMed ID: 10445388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat.
    Czachura JF; Rasmussen K
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Sep; 362(3):266-75. PubMed ID: 10997729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
    Jones CK; Eastwood BJ; Need AB; Shannon HE
    Neuropharmacology; 2006 Dec; 51(7-8):1172-80. PubMed ID: 17045620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: a dual probe microdialysis study in awake rat.
    Ferraro L; Fuxe K; Agnati L; Tanganelli S; Tomasini MC; Antonelli T
    Synapse; 2005 Mar; 55(4):230-41. PubMed ID: 15668907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of fluoxetine, sibutramine, sertraline and dexfenfluramine on the morphology of serotonergic nerve terminals using serotonin immunohistochemistry.
    Kalia M; O'Callaghan JP; Miller DB; Kramer M
    Brain Res; 2000 Mar; 858(1):92-105. PubMed ID: 10700602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
    Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
    Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the effects of the administration of fluoxetine and sertraline on the immune markers of the mu opioid receptor in the rat brain].
    Acebes I; Echevarría E; Abecia LC; Barbero I; Maza JL; Casis L
    Rev Neurol; 2000 Nov 16-30; 31(10):919-22. PubMed ID: 11244683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.